Researchers

TANIZAKI Junko

Faculty	Department of Medicine
Researchmap	https://researchmap.jp/tanizaki_j

Chromosomal Instability Is Associated with cGAS-STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer.
Kimio Yonesaka; Takashi Kurosaki; Junko Tanizaki; Hisato Kawakami; Kaoru Tanaka; Osamu Maenishi; Shiki Takamura; Kazuko Sakai; Yasutaka Chiba; Takeshi Teramura; Hiroki Goto; Eri Otsuka; Hiroaki Okida; Masanori Funabashi; Yuuri Hashimoto; Kenji Hirotani; Yasuki Kamai; Takashi Kagari; Kazuto Nishio; Kazuhiro Kakimi; Hidetoshi Hayashi
Cells 14 (6) 17, Mar. 2025
Detection of Overlooked Rare EGFR Mutations in Non‐small Cell Lung Cancer Using Multigene Testing
Naoki Shiraishi; Takayuki Takahama; Kazuko Sakai; Kaoru Tanaka; Yuzuki Nakagawa; Hiroaki Kanemura; Tomohiro Nakayama; Yusuke Kawanaka; Takashi Kurosaki; Shinichiro Suzuki; Tsutomu Iwasa; Junko Tanizaki; Chiaki Inagaki; Kimio Yonesaka; Kazuya Fukuoka; Tetsuya Mitsudomi; Kazuto Nishio; Hidetoshi Hayashi; Kazuhiko Nakagawa
Thoracic Cancer Feb. 2025 , Refereed
Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain
Yoshihiko Fujita; Hiromichi Matsuoka; Yasutaka Chiba; Junji Tsurutani; Takeshi Yoshida; Kiyohiro Sakai; Miki Nakura; Ryo Sakamoto; Chihiro Makimura; Yoichi Ohtake; Kaoru Tanaka; Hidetoshi Hayashi; Takayuki Takahama; Junko Tanizaki; Atsuko Koyama; Kazuto Nishio; Kazuhiko Nakagawa
Molecular and Clinical Oncology 22 (2) 29, Nov. 2024

Nivolumab for cancer of unknown primary (CUP): clinical efficacy and biomarker analysis from NivoCUP2 expanded access program (WJOG14620M) , J. Tanizaki; K. Yonemori; Y. Takiguchi; K. Akiyoshi; K. Komine; Y. Onozawa; M. Sato; K. Hirata; T.Onoe; T. Ishiguro; A. Ito; Y. Chiba; H. Watanabe; Y. Togashi; K. Sakai; K. Nishio; K.Nakagawa; H. Hayashi , 2024 ESMO , 15, Sep. 2024
Clinical features of long-term response to immune checkpoint inhibitors in patients with advanced or recurrent NSCLC , Waka Dohi; Hiroaki Kanemura; Junko Tanizaki; Shinichiro Suzuki; Takayuki Takahama; Kaoru Tanaka; Tsutomu Iwasa; Kimio Yonesaka; Hidetoshi Hayashi , 2024 世界肺癌学会 , 8, Sep. 2024
Phase Ia/Ib trial on the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M). , Hiroaki Kanemura; Junko Tanizaki; Koji Matsumoto; Toshiki Masuishi; Taichi Isobe; Hiroaki Kodama; Toshio Shimizu; Yu Sunakawa; Yasutaka Chiba; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Hidetoshi Hayashi , 2024 ASCO , 1, Jun. 2024

Current Status and Issues of “imNET“ Activities of the Immune-Related Adverse Events Management Team in Kindai Hospital , 高濱隆幸; 磯本晃佑; 鈴木慎一郎; 渡邉諭美; 金村宙昌; 稲垣千晶; 三谷誠一郎; 谷崎潤子; 吉田健史; 田中薫; 川上尚人; 岩朝勤; 米阪仁雄; 藤原季美子; 萩原智; 西山理; 桑原基; 竹久志穂; 高橋直美; 林秀敏 , 日本臨床腫瘍学会学術集会(CD-ROM) , 21st , 2024
Providing Anti-Lung Cancer Drug Therapy Based on Genetic Information by Comprehensive Genomic Profiling , 米阪仁雄; 稲垣千昌; 稲垣千昌; 高濱隆幸; 高濱隆幸; 白石直樹; 磯本晃佑; 金村宙昌; 鈴木慎一郎; 谷崎潤子; 田中薫; 林秀敏; 中川和彦 , 日本癌学会学術総会抄録集(Web) , 82nd , 2023
ニボルマブ+イピリムマブ併用療法中に敗血症との鑑別を要する免疫関連下垂体炎を発症した肺腺癌の1例 , 村田修一; 谷崎潤子; 岩朝勤; 黒崎隆; 田中薫; 林秀敏; 中川和彦; 濱有一郎 , 肺癌(Web) , 63 , 3 , 2023

Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Analysis of the risk factors for the development and severity of immune-related adverse events by immune checkpoint inhibitors , Kindai University